Yahoo Web Search

Search results

  1. Feb 28, 2017 · With these words, Emil Behring (1854 to 1917) and Shibasaburo Kitasato (1853 to 1931) began their groundbreaking paper on diphtheria and tetanus immunity in experimental animals . The study demonstrated that sera from rabbits infected with Clostridium tetani conferred protection to naive mice against live tetanus bacilli and against tetanus toxin.

  2. Mar 19, 2024 · In 1885 Kitasato moved to Berlin to join the laboratory of German bacteriologist Robert Koch. There, with Emil von Behring, he studied tetanus and diphtheria, two bacterial infections that cause symptoms through the secretion of toxins.

    • The Editors of Encyclopaedia Britannica
  3. Archive. Volume 71, Issue 1. Email alerts. Neurological stamp. Emil Adolph von Behring (1854–1917) and Shibasaburo Kitasato (1852–1931) LF HAAS. https://doi.org/10.1136/jnnp.71.1.62. Request Permissions.

    • Haas Lf
    • 2001
  4. Kitasato and Emil von Behring, working together in Berlin in 1890, announced the discovery of diphtheria antitoxin serum. Von Behring was awarded the 1901 Nobel Prize because of this work, but Kitasato was not.

    • Japanese
    • June 13, 1931 (aged 78), Tokyo, Japan
  5. Aug 25, 2021 · In 1889, Shibasaburō was the first to isolate and grow tetanus bacillus in pure culture, and in 1890, worked with fellow researcher Emil von Behring in developing a serum therapy for tetanus. Using attenuated forms of the infectious bacteria that cause tetanus, Behring and Shibasaburō inoculated rabbits, rats, and guinea pigs, and collected ...

  6. People also ask

  7. Apr 25, 2024 · Overview. Emil Adolf von Behring. (1854—1917) German bacteriologist. Quick Reference. (1854–1917) German immunologist. Behring was born in Hansdorf in Germany. He graduated in medicine at Berlin University and entered the Army Medical Corps before becoming (in 1888) a lecturer in the Army Medical College, Berlin.

  8. In 1890, an effective treatment for diphtheria – antitoxin – was discovered by Shibasaburo Kitasato and Emil von Behring in Germany. Pharmaceutical companies and public health agencies began to produce the new serum therapy in earnest. The New York City Health Department, in particular, pursued largescale antitoxin production.

  1. People also search for